AORT logo

AORT Artivion, Inc.

New York Stock Exchange · Medical - Devices · Healthcare

$18.53
-0.01 (-0.05%)

Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine perica…

Market Cap: $904.07Martivion.com

Price

$27.12-21.71%
$20.10$25.47$30.84$36.21
Apr 29Aug 7

Social Signal Score

44
5d
—
30d
43
4 mentions
+0.0%
60d
44
5 mentions
+0.0%
90d
44
5 mentions
+0.0%
news: 5

Analyst Ratings

12 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 2Sell 0Strong Sell 0
Avg price target$35.33+90.7%
Low $30Median $31High $45
Current Consensus

Revenue

$123.79M+174.91%
$44.00M$71.25M$98.50M$125.76M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.21
$0.21–$0.22
3 analysts
FY2026
$-0.43-303% YoY
$-16.09–$15.66
5 analysts
FY2027
$0.14
$0.13–$0.15
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
James Patrick Mackin
Sector
Healthcare
Industry
Medical - Devices
Employees
1,800
Beta
1.28
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
1.63
artivion.com